These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11583649)

  • 1. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia.
    Cunha BA
    Am J Med; 2001 Oct; 111(5):412-3. PubMed ID: 11583649
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
    Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
    Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
    Cassiere HA; Fein AM
    Semin Respir Infect; 1998 Mar; 13(1):36-42. PubMed ID: 9543474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing antibiotics for community acquired pneumonia.
    Mehta PN
    Indian Pediatr; 2003 Oct; 40(10):958-64. PubMed ID: 14581733
    [No Abstract]   [Full Text] [Related]  

  • 5. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
    See S
    J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
    [No Abstract]   [Full Text] [Related]  

  • 6. When to switch therapy in patients with severe community-acquired pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A
    Ann Intern Med; 2008 Apr; 148(8):625; author reply 625-6. PubMed ID: 18413627
    [No Abstract]   [Full Text] [Related]  

  • 7. How short can courses be in lower respiratory tract infections?
    Siegel R
    J Int Med Res; 2000; 28 Suppl 1():37A-47A. PubMed ID: 11092228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia.
    Ramirez JA
    Ann Pharmacother; 1998 Jan; 32(1):S22-6. PubMed ID: 9475836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia.
    Press RA
    Pharmacotherapy; 2001 Jul; 21(7 Pt 2):100S-104S. PubMed ID: 11446520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CAP on antibiotic duration.
    Wunderink RG
    Am J Respir Crit Care Med; 2006 Jul; 174(1):3-5. PubMed ID: 16793998
    [No Abstract]   [Full Text] [Related]  

  • 11. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.
    Rhew DC; Tu GS; Ofman J; Henning JM; Richards MS; Weingarten SR
    Arch Intern Med; 2001 Mar; 161(5):722-7. PubMed ID: 11231705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem (Invanz)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2002 Mar; 44(1126):25-6. PubMed ID: 11941264
    [No Abstract]   [Full Text] [Related]  

  • 13. Community-acquired pneumonia.
    Prina E; Ranzani OT; Torres A
    Lancet; 2015 Sep; 386(9998):1097-108. PubMed ID: 26277247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.
    Ramirez JA; Vargas S; Ritter GW; Brier ME; Wright A; Smith S; Newman D; Burke J; Mushtaq M; Huang A
    Arch Intern Med; 1999 Nov; 159(20):2449-54. PubMed ID: 10665893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Switch therapy for community acquired pneumonia].
    Aoshima M
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():326-30. PubMed ID: 17455640
    [No Abstract]   [Full Text] [Related]  

  • 16. Community acquired pneumonia.
    Al-Qadi MO; Al-Alwan A; Opal SM; Cillley B; Silverblatt FJ
    Med Health R I; 2010 Jul; 93(7):196-200. PubMed ID: 20707009
    [No Abstract]   [Full Text] [Related]  

  • 17. Getting physicians to make "the switch": the role of clinical guidelines in the management of community-acquired pneumonia.
    Hagaman JT; Yurkowski P; Trott A; Rouan GW
    Am J Med Qual; 2005; 20(1):15-21. PubMed ID: 15782751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is short-course treatment an option for community-acquired pneumonia?].
    Petitpretz P
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S106-7. PubMed ID: 18598857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.